Gardner's syndrome

Cause

Gardner syndrome is caused by mutation in the adenomatous polyposis coli (APC gene), located on chromosome 5q21 (band q21 on chromosome 5). FAP is defined by the development of hundreds or thousands of polyps in the colon. Gardner syndrome is set apart as a subtype because, in addition to colonic polyps, there are also extra-colonic growths (both malignant and benign). There are many terms used to describe "APC-associated polyposis condition" including FAP, attenuated FAP, Gardner syndrome, Turcot syndrome, and gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS). There is a movement toward no longer using the terms Gardner Syndrome or Turcot Syndrome since both are part of the FAP spectrum. Gardner syndrome and Turcot syndrome are regarded primarily for historical interest.

Genetics

Gardner syndrome is inherited in an autosomal dominant manner. Typically, one parent has Gardner syndrome. Each of their children, male and female alike, is at 50% risk of inheriting the gene for Gardner syndrome.

Diagnosis

Gardner syndrome consists of adenomatous polyps of the gastrointestinal tract, Gardner fibromas, desmoid tumors, osteomas, epidermoid cysts, lipomas, dental abnormalities, and periampullary carcinomas. The incidence of the syndrome is 1:14,025 with an equal sex distribution. It is determined by the autosomal dominant familial polyposis coli gene (APC) on chromosome 5.

Gardner syndrome can be identified based on oral findings, including multiple impacted and supernumerary teeth, multiple jaw osteomas that give a "cotton-wool" appearance to the jaws, as well as multiple odontomas, congenital hypertrophy of the retinal pigment epithelium (CHRPE), in addition to multiple adenomatous polyps of the colon. Gardner syndrome is also associated with familial adenomatous polyposis and may manifest as aggressive fibromatosis (desmoid tumors) of the retroperitoneum.

Desmoid tumors arise most frequently from the aponeurosis of the rectus abdominal muscle of multiparous women. The extra-abdominal form is rare and desmoids of the breast may arise in the mammary gland or may occur as an extension of a lesion arising from the muscles of the chest wall. The incidence of mammary desmoid tumors is less than 0.2% of primary breast neoplasms. In Gardner's syndrome, the incidence ranges from 4% to 17%. Desmoid tumors associated with Gardner's syndrome have been shown to have an alteration of the β-catenin pathway and over express β-catenin.

Treatment

There is no cure for Gardner Syndrome. Treatments focus on alleviating symptoms and reducing risk of cancer. Treatments for desmoid tumors may include surgery, NSAIDS, anti-estrogen medications, radiation therapy and chemotherapy.

Eponym

The syndrome is named for Eldon J. Gardner (1909–1989), an American geneticist who first described it in 1951.

References

References

1. (22 October 2017). "Dermatology".
2. (22 October 2017). "Dermatology".
3. {{OMIM. 175100
4. (February 2003). "Common benign skin tumors". Am Fam Physician.
5. "Gardner syndrome {{!}} Genetic and Rare Diseases Information Center (GARD) – an NCATS Program".
6. (2012-06-26). "Gardner Syndrome". American Society of Clinical Oncology.
7. "Gardner syndrome {{!}} Genetic and Rare Diseases Information Center (GARD) – an NCATS Program".
8. "Gardner syndrome {{!}} Genetic and Rare Diseases Information Center (GARD) – an NCATS Program".
9. (2012). "Desmoid tumour of the breast as a manifestation of Gardner's syndrome". Int J Surg Case Rep.
10. (March 2020). "Soft Tissue Special Issue: Fibroblastic and Myofibroblastic Neoplasms of the Head and Neck". Head and Neck Pathology.
11. DeVita. ''Cancer, Principles and Practice of Oncology'', 8th Ed. p. 1742.
12. Gardner EJ. (June 1951). "A genetic and clinical study of intestinal polyposis, a predisposing factor for carcinoma of the colon and rectum". Am. J. Hum. Genet..